Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof
US12006318B2 · kind B2 · utility
0Cited by
1References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2020 |
| Grant date | Jun 11, 2024 |
| Priority date | — |
| Expiry date | Dec 7, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Crystalline forms of a C-C chemokine receptor type 4 (CCR4) antagonist, oral dosage forms of same and methods of using and preparing same, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.